Breaking News

Emmecell Appoints Ramin Valian as CEO

Valian brings over 20 years of global commercial and strategic leadership in eye care.

Author Image

By: Charlie Sternberg

Associate Editor

Emmecell, a clinical-stage biotechnology company pioneering magnetic cell delivery technologies for ophthalmic disease, has appointed Ramin Valian as Chief Executive Officer (CEO). As CEO, Valian will oversee corporate strategy, clinical and regulatory development, partnerships, and operational growth as the company prepares for pivotal cornea trials and commercialization. Experience A veteran biopharmaceutical executive, Valian brings over 20 years of global commercial and strategic le...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics